摘要
目的: 蛋白质去甲酰化是一种高度动态和可逆的翻译后修饰,涉及小泛素样修饰剂(SUMO)与靶蛋白赖氨酸残基的共价结合。与泛素化类似,在e1,e2和几个e3连接酶的催化下苏美化。然而,sumoylation通常不会引起蛋白质降解,而是通过多种机制改变靶功能。越来越多的证据表明,苏门答腊在人类疾病的发病机制中起着关键作用,包括神经元变性、癌症和心脏病等。我们和其他人已经证明,苏门答腊与小鼠的眼睛发育密切相关。然而,在正常和致病性视网膜中,苏美化机制的表达还没有表现出来。在世界范围内,年龄相关性黄斑变性(AMD)是导致老年人不可逆性失明的主要原因。在本研究中,我们研究了正常小鼠和碘酸钠诱导的AMD小鼠模型中主要的去甲酰化酶的表达。 方法: 实验采用4周龄的C57BL/6J小鼠。用固体NaIO3在PBS中新鲜制备无菌1% NaIO3溶液。实验小鼠注射70 mg/kg NaIO3,与对照组的PBS体积相似。整夜进行眼球摘除和FAA固定浸泡,并进行眼部横截面处理。固定后,眼睛横截面脱水,石蜡包埋,使用旋转切片机切割6 mm横截面。然后石蜡切片用苏木精和伊红染色,观察小鼠视网膜厚度以评估组织病理学变化。 结果: 治疗后一天,注射NaIO3的小鼠RPE中E1, E2和 E3连接酶PIAS1的RNA水平显著下降。在这个时间点,PIAS1的蛋白质水平持续下降。在治疗后期(注射后3天),注射Naio3的小鼠视网膜中发现E1酶SAE1/UBA2的表达显著降低。相反,在注入的视网膜中发现E3连接酶RanBP2显著增加。 结论: 综上所述,我们的结果首次证明氧化应激诱导视网膜变性过程中苏门答腊途径酶的动态表达。在视网膜色素上皮(RPE)和视网膜变性的过程中,E1, E2 和 E3酶的动态表达,揭示了sumoylation在AMD发病机制中的潜在调控作用。
关键词: 年龄相关性黄斑变性,氧化应激,sumoylation酶, E1
Current Molecular Medicine
Title:Sodium Iodate-Induced Mouse Model of Age-Related Macular Degeneration Displayed Altered Expression Patterns of Sumoylation Enzymes E1, E2 and E3
Volume: 18 Issue: 8
关键词: 年龄相关性黄斑变性,氧化应激,sumoylation酶, E1
摘要: Purpose: Protein sumoylation is a highly dynamic and reversible post-translational modification, involving covalently conjugation of the small ubiquitin-like modifier (SUMO) to the lysine residue of the target protein. Similar to ubiquitination, sumoylation is catalyzed by E1, E2 and several E3 ligases. However, sumoylation usually does not cause protein degradation but alter the target function through diverse mechanisms. Increasing evidences have shown that sumoylation plays pivotal roles in the pathogenesis of human diseases, including neuron degeneration, cancer and heart disease, etc. We and others have shown that sumoylation is critically implicated in mouse eye development. However, the expression of sumoylation machinery has not been characterized in normal and pathogenic retina. Worldwide, age-related macular degeneration (AMD) is the leading cause of irreversible blindness in aged person. In the present study, we investigated the expression of the major sumoylation enzymes in normal mice and sodium iodateinduced AMD mouse model.
Methods: Four-week-old C57BL/6J mice were used in our experiment. A sterile 1% NaIO3 solution was freshly prepared in PBS from solid NaIO3. Experimental mice were injected with 70 mg/kg NaIO3, and similar volumes of PBS as control. Eyes were enucleated and immersion in FAA fixation overnight and processed for eye cross-sections. After fixation, cross sections eyes were dehydrated, embedded in paraffin, and 6 mm transverse sections were cut using the rotary microtome. Then paraffin sections were stained with hematoxylin and eosin (H&E), and mouse retinal thickness was observed to assess the histopathologic changes.
Results: Significantly declined RNA levels of E1, E2 and E3 ligase PIAS1 in NaIO3-injected mouse RPE one day-post treatment. Consistently, the protein level of PIAS1 was also decreased at this time point. At the late stage of treatment (three days post-injection), significantly reduced expression of E1 enzyme SAE1/UBA2 was detected in NaIO3-injected mouse retinas. In the contrary, dramatically increased E3 ligase RanBP2 was found in the injected-retinas.
Conclusion: Together, our results demonstrated for the first time the dynamic expression of sumoylation pathway enzymes during the progression of retina degeneration induced by oxidative stress. Dynamic expression of E1, E2 and E3 enzymes were found during the time course of RPE and retina degeneration, which revealed the potential regulatory roles of sumoylation in AMD pathogenesis.
Export Options
About this article
Cite this article as:
Sodium Iodate-Induced Mouse Model of Age-Related Macular Degeneration Displayed Altered Expression Patterns of Sumoylation Enzymes E1, E2 and E3, Current Molecular Medicine 2018; 18 (8) . https://dx.doi.org/10.2174/1566524019666190112101147
DOI https://dx.doi.org/10.2174/1566524019666190112101147 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Vascular Pharmacology Editorial (Thematic Issue: Treating Major Age-Related Diseases in Older and Oldest Old Patients)
Current Pharmaceutical Design AMP-Activated Protein Kinase: Structure and Regulation
Current Protein & Peptide Science Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations
Current Pharmacogenomics and Personalized Medicine The Effects of Sevoflurane or Remifentanil on the Stress Response to Surgical Stimulus
Current Pharmaceutical Design Lycopene Modulation of Molecular Targets Affected by Smoking Exposure
Current Cancer Drug Targets Direct Somatic Cell Reprogramming: Treatment of Cardiac Diseases
Current Gene Therapy Mechanosensitive Channels: Therapeutic Targets in the Myocardium?
Current Pharmaceutical Design Effects of Verbascoside Administration on the Blood Parameters and Oxidative Status in Jennies and Their Suckling Foals: Potential Improvement of Milk for Human Use
Endocrine, Metabolic & Immune Disorders - Drug Targets Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design UKPDS Risk Engine, Decode and Diabetes PHD Models for the Estimation of Cardiovascular Risk in Patients with Diabetes
Current Diabetes Reviews MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Recent Applications of Cyclodextrins as Food Additives and in Food Processing
Current Nutrition & Food Science C-Reactive Protein and Hypertension: Is there A Causal Relationship?
Current Pharmaceutical Design Therapeutic Angiogenesis: Recent and Future Prospects of Gene Therapy in Peripheral Artery Disease
Current Gene Therapy The Role of High-Density Lipoprotein Cholesterol in the Prevention and Possible Treatment of Cardiovascular Diseases
Current Molecular Medicine Managing Erectile Dysfunction in Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents